Lev Pharmaceuticals Announces Final Patient Treated In Pivotal Phase III HAE Trial
Thu, 18 Jan 2007 08:00 AM EST
... Lev Pharmaceuticals, Inc. (Lev) (OTC Bulletin Board: LEVP. [click link for full article] ...
Related Topics
- Clinical Trials
- Patient Issues
- Antithrombin III
- Personal Medical Records
- Familial Dysautonomia
- Pancreatic Cancer
- Confusion and changes in mental status may develop if the condition is not treated.
- Fatigue and shortness of breath (if poor heart function isn't treated)
- Advocacy
- Food Recommendations: South Beach Diet - Phase 2
- Food Recommendations: South Beach Diet - Phase 1
- Congenital antithrombin III deficiency
- Cranial mononeuropathy III - compression type
- Cranial mononeuropathy III - diabetic type
- Antithrombin
- Osteogenesis imperfecta, type III
- Pulmonary Fibrosis
- Desipramine
- Trastuzumab
- Coccidioidomycosis

Not Signed In -

